Contact
searchSearch
HMP Global

Advertisement

Advertisement

ADVERTISEMENT

Prurigo Nodularis Excellence Forum

Gil Yosipovitch, MD,
Videos
Dupilumab for Adults With Prurigo Nodularis: A Critical Review
11/14/2024
In this feature interview, Gil Yosipovitch, MD, shares his expert insights into dupilumab for adult patients with prurigo nodularis.
In this feature interview, Gil Yosipovitch, MD, shares his expert insights into dupilumab for adult patients with prurigo nodularis.
In this feature interview, Gil...
11/14/2024
The Dermatologist
skin of color prurigo nodularis
Conference Coverage
Prurigo Nodularis: Features and Burden of Disease
04/26/2023
Shawn Kwatra, MD, described the clinical features, pathophysiology, and burden of disease in prurigo nodularis.
Shawn Kwatra, MD, described the clinical features, pathophysiology, and burden of disease in prurigo nodularis.
Shawn Kwatra, MD, described the...
04/26/2023
The Dermatologist
Sonja Ständer, MD, specializes in novel therapies for chronic pruritus and chronic prurigo including prurigo nodularis.
Videos
New Guidelines for Managing Prurigo
10/19/2021
Following her presentation at Dermatology Week, Dr Sonja Stander presented her insights into the prurigo nodularis guidelines in this video.
Following her presentation at Dermatology Week, Dr Sonja Stander presented her insights into the prurigo nodularis guidelines in this video.
Following her presentation at...
10/19/2021
The Dermatologist
Dr Sonja Stander, an expert on prurigo and prurigo nodularis, discussed treatment algorithms for these diseases.
Videos
Defining the Treatment Algorithm for Prurigo
09/16/2021
Prior to her presentation at Dermatology Week, Dr Sonja Stander discussed the treatment algorithm for prurigo nodularis in this video.
Prior to her presentation at Dermatology Week, Dr Sonja Stander discussed the treatment algorithm for prurigo nodularis in this video.
Prior to her presentation at...
09/16/2021
The Dermatologist

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Current Issue

October 2024
Volume 32
Issue 7
Current Issue
Issue Archive

Advertisement

Advertisement

Advertisement

Advertisement

Popular Articles

First-in-Class Therapy for Facial Redness of Rosacea Approved
08/29/2013
Mirvaso® (brimonidine) topical gel, 0.33%, from Galderma Laboratories, LP, received FDA approval for the topical treatment of the facial erythema (redness) of rosacea in adults 18 years of age or older and should be available this month....
Mirvaso® (brimonidine) topical gel, 0.33%, from Galderma Laboratories, LP, received FDA approval for the topical treatment of the facial erythema (redness) of rosacea in adults 18 years of age or older and should be available this month....
Mirvaso® (brimonidine) topical...
08/29/2013
The Dermatologist
The Dermatopathologist
Eosinophilic Angiocentric Fibrosis Coexisting With Granuloma Faciale
10/28/2016
In this case, a rare form of tumefactive fibrosing vasculitis presents as an orbital pseudotumor.
In this case, a rare form of tumefactive fibrosing vasculitis presents as an orbital pseudotumor.
In this case, a rare form of...
10/28/2016
The Dermatologist
FDA Issues Consumer Update about Potential Dangers of Temporary Black Henna Tattoos
04/04/2013
The FDA has issued a Consumer Update about the potential dangers of temporary black henna tattoos.According to the FDA, several reports have been received through MedWatch, the Administration’s safety informa­tion and adverse event...
The FDA has issued a Consumer Update about the potential dangers of temporary black henna tattoos.According to the FDA, several reports have been received through MedWatch, the Administration’s safety informa­tion and adverse event...
The FDA has issued a Consumer...
04/04/2013
The Dermatologist
News
Long-Term Safety Data for Psoriasis Drug Presented at EADV Congress
09/27/2016
Long-term safety findings from ongoing clinical trials of apremilast, the oral, selective inhibitor of phosphodiesterase 4 (PDE4) from Celgene Corporation, were presented at the European Academy of Dermatology and Venereology (EADV) Annual...
Long-term safety findings from ongoing clinical trials of apremilast, the oral, selective inhibitor of phosphodiesterase 4 (PDE4) from Celgene Corporation, were presented at the European Academy of Dermatology and Venereology (EADV) Annual...
Long-term safety findings from...
09/27/2016
The Dermatologist
Promius Pharma Announces 50% Expansion of Sales Force
01/02/2013
Promius Pharma has announced a 50% expansion of the company’s sales force that is effectively immediately.According to Rob D’Urso, head of sales and marketing at Promius, the company is in “growth mode.”“Promius Pharma is gearing up for...
Promius Pharma has announced a 50% expansion of the company’s sales force that is effectively immediately.According to Rob D’Urso, head of sales and marketing at Promius, the company is in “growth mode.”“Promius Pharma is gearing up for...
Promius Pharma has announced a...
01/02/2013
The Dermatologist

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Subscribe

The Dermatologist Newsletter

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Latest Quizzes and Trivia

Atopic dermatitis
Quiz
Pediatric Atopic Dermatitis Management
11/11/2024
1. What alternative therapies does Dr Swanson suggest for children who have difficulty adhering to topical treatment regimens?a) Antibioticsb) Injectable or oral medicationsc) UV light therapyd) Homeopathic remedies2. According to Dr Swanson,...
1. What alternative therapies does Dr Swanson suggest for children who have difficulty adhering to topical treatment regimens?a) Antibioticsb) Injectable or oral medicationsc) UV light therapyd) Homeopathic remedies2. According to Dr Swanson,...
1. What alternative therapies...
11/11/2024
The Dermatologist
Illustration of a T cell
QUIZ
Test Your Knowledge: The Immunology of Alopecia Areata
11/04/2024
11/04/2024
The Dermatologist
psoriasis
Quiz
Long-Term Safety of Risankizumab
10/18/2024
What were the primary findings regarding the long-term safety of risankizumab?
What were the primary findings regarding the long-term safety of risankizumab?
What were the primary findings...
10/18/2024
The Dermatologist
Brain
Quiz
Barriers to Mental Health Support
10/10/2024
What was the first barrier to mental health support for patients with atopic dermatitis identified in the NEA survey?
What was the first barrier to mental health support for patients with atopic dermatitis identified in the NEA survey?
What was the first barrier to...
10/10/2024
The Dermatologist
AD
Quiz
QUIZ: Psoriasis and Atopic Dermatitis: Nonsteroidal Topical Therapies
09/15/2024
1. According to Dr Linda Stein Gold, how do nonsteroidal topical therapies compare to traditional steroid-based treatments for managing psoriasis and AD?a) They are less effective but safer.b) They are as effective as mid-potency steroids and...
1. According to Dr Linda Stein Gold, how do nonsteroidal topical therapies compare to traditional steroid-based treatments for managing psoriasis and AD?a) They are less effective but safer.b) They are as effective as mid-potency steroids and...
1. According to Dr Linda Stein...
09/15/2024
The Dermatologist
psoriasis
Quiz
QUIZ: Topical PDE-4 Inhibitors For Atopic Dermatitis, Seborrheic Dermatitis, and Psoriasis
08/10/2024
What strategies did Dr Merola emphasize for atopic dermatitis?
What strategies did Dr Merola emphasize for atopic dermatitis?
What strategies did Dr Merola...
08/10/2024
The Dermatologist
contact dermtitis + Neck + Eczema + rash
Quiz
QUIZ: Patient Experiences in Contact Dermatitis and Patch Testing
07/14/2024
What is a common challenge for patients during the patch testing week?
What is a common challenge for patients during the patch testing week?
What is a common challenge for...
07/14/2024
The Dermatologist
gloves hands
Quiz
Quiz: Barrier to Mental Health Support in Patients with Atopic Dermatitis
05/30/2024
According to a recent interview with Jessica Johnson, MPH, what is a significant barrier to seeking mental health support among patients with atopic dermatitis?
According to a recent interview with Jessica Johnson, MPH, what is a significant barrier to seeking mental health support among patients with atopic dermatitis?
According to a recent interview...
05/30/2024
The Dermatologist
Atopic dermatitis
Quiz
Quiz: Atopic Dermatitis Spotlight
05/06/2024
Which class of medications received a "general thumbs up" in the latest guidelines for atopic dermatitis management due to their efficacy and low cancer risk?
Which class of medications received a "general thumbs up" in the latest guidelines for atopic dermatitis management due to their efficacy and low cancer risk?
Which class of medications...
05/06/2024
The Dermatologist
basal cell carcinoma
Quiz
True or False: Basal Cell Carcinoma on Vermilion Lip
05/01/2024
Is basal cell carcinoma on the vermilion lip a distinctly rare phenomenon, sparsely documented in existing literature?
Is basal cell carcinoma on the vermilion lip a distinctly rare phenomenon, sparsely documented in existing literature?
Is basal cell carcinoma on the...
05/01/2024
The Dermatologist

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use

Advertisement

Advertisement